FSPKF
Price
$20.95
Change
-$0.84 (-3.85%)
Updated
Sep 29 closing price
Capitalization
12.88B
FZMD
Price
$0.06
Change
-$0.04 (-40.00%)
Updated
Sep 26 closing price
Capitalization
4.14M
Interact to see
Advertisement

FSPKF vs FZMD

Header iconFSPKF vs FZMD Comparison
Open Charts FSPKF vs FZMDBanner chart's image
Fisher & Paykel Healthcare
Price$20.95
Change-$0.84 (-3.85%)
Volume$1K
Capitalization12.88B
Fuse Medical
Price$0.06
Change-$0.04 (-40.00%)
Volume$755
Capitalization4.14M
FSPKF vs FZMD Comparison Chart in %
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FSPKF vs. FZMD commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPKF is a Hold and FZMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (FSPKF: $20.95 vs. FZMD: $0.06)
Brand notoriety: FSPKF and FZMD are both not notable
FSPKF represents the Pharmaceuticals: Other, while FZMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FSPKF: 107% vs. FZMD: 51%
Market capitalization -- FSPKF: $12.88B vs. FZMD: $4.14M
FSPKF [@Pharmaceuticals: Other] is valued at $12.88B. FZMD’s [@Medical/Nursing Services] market capitalization is $4.14M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.16B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $234.25B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.38B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FSPKF’s FA Score shows that 0 FA rating(s) are green whileFZMD’s FA Score has 1 green FA rating(s).

  • FSPKF’s FA Score: 0 green, 5 red.
  • FZMD’s FA Score: 1 green, 4 red.
According to our system of comparison, FZMD is a better buy in the long-term than FSPKF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FSPKF’s TA Score shows that 2 TA indicator(s) are bullish while FZMD’s TA Score has 3 bullish TA indicator(s).

  • FSPKF’s TA Score: 2 bullish, 2 bearish.
  • FZMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, FSPKF is a better buy in the short-term than FZMD.

Price Growth

FSPKF (@Pharmaceuticals: Other) experienced а -3.85% price change this week, while FZMD (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was +2.89%, and the average quarterly price growth was +20.22%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.81%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +19.30%.

Industries' Descriptions

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.81% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FSPKF($12.9B) has a higher market cap than FZMD($4.14M). FSPKF has higher P/E ratio than FZMD: FSPKF (56.58) vs FZMD (1.34). FSPKF YTD gains are higher at: 3.713 vs. FZMD (-25.259). FSPKF has higher annual earnings (EBITDA): 654M vs. FZMD (4.35M). FSPKF has more cash in the bank: 264M vs. FZMD (253K). FZMD has less debt than FSPKF: FZMD (2.22M) vs FSPKF (153M). FSPKF has higher revenues than FZMD: FSPKF (1.28B) vs FZMD (18.4M).
FSPKFFZMDFSPKF / FZMD
Capitalization12.9B4.14M311,745%
EBITDA654M4.35M15,031%
Gain YTD3.713-25.259-15%
P/E Ratio56.581.344,219%
Revenue1.28B18.4M6,957%
Total Cash264M253K104,348%
Total Debt153M2.22M6,889%
FUNDAMENTALS RATINGS
FSPKF vs FZMD: Fundamental Ratings
FSPKF
FZMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
45100
PRICE GROWTH RATING
1..100
5565
P/E GROWTH RATING
1..100
9814
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FZMD's Valuation (44) in the null industry is somewhat better than the same rating for FSPKF (95). This means that FZMD’s stock grew somewhat faster than FSPKF’s over the last 12 months.

FZMD's Profit vs Risk Rating (100) in the null industry is in the same range as FSPKF (100). This means that FZMD’s stock grew similarly to FSPKF’s over the last 12 months.

FSPKF's SMR Rating (45) in the null industry is somewhat better than the same rating for FZMD (100). This means that FSPKF’s stock grew somewhat faster than FZMD’s over the last 12 months.

FSPKF's Price Growth Rating (55) in the null industry is in the same range as FZMD (65). This means that FSPKF’s stock grew similarly to FZMD’s over the last 12 months.

FZMD's P/E Growth Rating (14) in the null industry is significantly better than the same rating for FSPKF (98). This means that FZMD’s stock grew significantly faster than FSPKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FSPKFFZMD
RSI
ODDS (%)
Bearish Trend 3 days ago
45%
Bullish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
45%
Bearish Trend 3 days ago
58%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHLD77.523.26
+4.39%
Resolute Holdings Management
IMVT16.900.17
+1.02%
Immunovant
CDW159.27-0.15
-0.09%
CDW Corp
NA5.60-0.07
-1.23%
Nano Labs Ltd
SINT3.94-0.17
-4.14%
SiNtx Technologies Inc.

FSPKF and

Correlation & Price change

A.I.dvisor tells us that FSPKF and ANSLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and ANSLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSPKF
1D Price
Change %
FSPKF100%
N/A
ANSLY - FSPKF
26%
Poorly correlated
N/A
OLYMY - FSPKF
25%
Poorly correlated
+4.25%
TMDX - FSPKF
25%
Poorly correlated
-0.33%
BRSYF - FSPKF
22%
Poorly correlated
N/A
TCHBF - FSPKF
22%
Poorly correlated
N/A
More

FZMD and

Correlation & Price change

A.I.dvisor tells us that FZMD and GNGBY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
GNGBY - FZMD
16%
Poorly correlated
N/A
DSRLF - FZMD
9%
Poorly correlated
N/A
GNNDY - FZMD
7%
Poorly correlated
+2.71%
FSPKF - FZMD
6%
Poorly correlated
N/A
ESLOY - FZMD
6%
Poorly correlated
+0.83%
More